Abstract
Purpose: Our purpose was to determine the specific anti-phospholipid antibodies (APAs) that should be evaluated to identify individuals at risk for implantation failure associated with reproductive autoimmune failure syndrome (RAFS).
Methods: The prevalence of APAs among 312 women with implantation failure was compared with that of 100 fertile control women. To be included in the implantation failure group, each woman had to have had at least 12 embryos transferred without subsequent positive pregnancy test. Enzyme-linked immunoabsorbant assay was used to measure IgG, IgM, and IgA anticardiolipin, antiphosphatidyl ethanol-amine, antiphosphatidyl inositol, antiphospatidic acid, antiphosphatidyl glycerol, antiphosphatidyl choline, and antiphosphatidyl serine.
Results: When the values for each of the seven APAs in three isotypes were compared between women with implantation failure and the control population, all of the APAs tested had a significantly higher frequency among women with implantation failure. Positive APAs were detected in 69 (22%) of the 312 women with implantation failure compared with 5 (5%) of the 100 control women (P < 0.0001). Anticardiolipin antibodies were found in 13 (4%) of the 312 women with implantation failure and none of the controls. Fifty-six (18%) of the 312 with implantation failure were negative for anticardiolipin antibodies but had positive values of other APAs.
Conclusions: A complete APA panel using seven isotypes is necessary for diagnosing implantation failure associated with RAFS. If only anticardiolipin antibody is measured, 4% (13/312) of the positive APAs are detected, and 81% (56/69) of women with implantation failure associated with RAFS will have the diagnosis missed.
Similar content being viewed by others
REFERENCES
Cowchock S, Smith JB, Gocial B: Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986;155:1002–1010
Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D: Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion: A controlled prospective study of 44 women. Arth Rheum 1987;30:601–606
Triplett DA: Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989;20:52–67
Rote NA, Dostal-Johnson DA, Branch DW: Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidyl-serine and cardiolipin. Am J Obstet Gynecol 1990;163:575–584
Roussev RG, Kaider BD, Price DE, Coulam CB: Laboratory evaluation of women experiencing reproductive failure. Am J Reprod Immunol 1996;35:415–420
Yetman DL, Kutteh WH: Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996;66:540–546
Matzner W, Chong P, Xu G, Ching W: Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994;39:27–30
Gilman-Sachs A, Lubinski J, Beer AE, Brend S, Beaman KD: Patterns of antiphospholipid antibody specificities. J Clin Lab Immunol 1991;35:83–88
Branch DW, Silver R, Pierangeli S, Van Leeuwen I, Harris EN: Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls and antiphospholipid syndrome. Obstet Gynecol 1997;89:549–555
Hughes GR, Harrison EN, Gharavi AE: The anticardiolipin syndrome. J Rheumatol 1986;13:486–489
Bringly PJ, Hoffbrand BI: Antiphospholipid antibody syndrome: A review. J Roy Soc Med 1987;80:445–448
Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989;160:1376–1385
Nilsson IM, Astedt B, Hedner U, Berezin D: Intrauterine death and circulating anticoagulant (“antithromboplastin”). Acta Med Scand 1975;197:153–159
Gleicher N, El-Roeiy A: The reproductive autoimmune failure syndrome. Am J Obstet Gynecol 1988;159:223–117
El Roeiy A, Gleicher N, Confino E, Friberg J, Dudkiewicz AB: Correlation between peripheral blood and follicular fluid: Autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987;70:163–170
Fisch B, Rikover Y, Shohat L, Zurgil N, Tadir Y, Ovadia J, Witz IP, Yron I: The relationship between in vitro fertilization and naturally occurring antibodies: Evidence for increased production of antiphospholipid autoantibodies. Fertil Steril 1991;56:718–724
Birkenfield A, Mukaida T, Minichiello L, Jackson M, Kase NG, Yemini M: Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994;31:65–68
Geva E, Yaron Y, Lessing JB, Yovel I, Vardinon N, Burke M, Amit A: Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril 1994;62:802–806
Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P: High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2278–2283
Gleicher N, Liu HC, Dudkiewicz A, Rosenwaks Z, Kaberlein G, Pratt D, Karande V: Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. Am J Obstet Gynecol 1994;170:1145–1149
Nipp MM, Taylor PV, Rutherford AJ, Hancock KW: Autoantibodies and follicular fluids of infertile patients: Relation to reproductive outcome after in vitro fertilization. Hum Reprod 1995;10:2564–2569
Fisch B, Fried S, Manor Y, Ovadia J, Witz IP, Yron I: Increased antiphospholipid antibody activity in in vitro fertilization patients is not treatment dependent but rather an inherent characteristic of infertile state. Am J Reprod Immunol 1995;34:370–374
Kaider BD, Price BE, Roussev RG, Coulam CB: Antiphospholipid antibody prevalence in patients with IVF failure. Am J Reprod Immunol 1996;35:388–393
Birdsall M, Lockwood GM, Ledger WL, Johnson PM, Chamley LW: Antiphospholipid antibodies in women having in vitro fertilization. Hum Reprod 1996;11:1185–1189
Schenk LM, Butler, L, Morris JP, et al.: Heparin and aspirin treatment yields higher implantation rates in IVFF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. American Society of Reproductive Medicine Meeting, Boston, MA, November 1996, abstract 0-076
Kutteh WH, Yetman DL, Chantiles SJ, Cr1ain J: Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: Role of heparin and aspirin. Hum Reprod 1997;12:1171–1175
Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott RT: Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertil Steril 1997;67:1084–1090
Kowalik A, Vichin M, Lui HC, Branch W, Berkeley AS: Midfollicular anticardiolipin and antiphosphatidyl serine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997;68:298–304
Theofilopolous AN: Autoimmunity in basic and clinical immunology. In Basic and Clinical Immunology, DE Stites, ID Stobo, HH Fudenberg, JV Wells (eds). Los Altos, CA: Lange Medical, 1985, pp 153–156
Coulam CB, Krysa LLW, Bustillo M: Intravenous immunoglobulin for in vitro fertilization failure. Hum Reprod 1995;9:2265–2269
Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC: The prevalence and biological significance of lupus anticoagulant and cardiolipin antibodies in general obstetric population. Am J Obstet Gynecol 1989;161:369–373
El-Roeiy A, Gleicher N: Definition of normal autoantibody levels in an apparently healthy population. Obstet Gynecol 1996;174:1584–1589
Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584–1589
Shoenfeld Y, Schwartz RS: Genetic and immunologic factors in autoimmune diseases. N Engl J Med 1984;311:101
Chamely LW, McKay EJ, Rattison NS: Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: A mechanism for thrombosis. Thromb Res 1993;71:103–111
Rote NS: Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1996;35:394–401
Gleicher N, Harlow L, Zilberstein M: Regulatory effect of antiphospholipid antibodies on signal transduction: A possible model for antibody induced reproductive failure. Am J Obstet Gynecol 1992;167:637–642
Rote NS, Vogt E, Se Vere G, Obringer AR, Ng AK: The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol 1997 (in press)
Tartakovsky B, Bermas BL, Sthoeger Z, Shearer GM, Mozes E: Defective maternal-fetal interaction in a murine autoimmune model. Hum Reprod 1996;11:2408–2411
Schick PK, Kurica KB, Chacko GK: Localization of phosphatidyl ethanolamine and phosphatidyl serine in the human platelet plasma membrane. J Clin Invest 1976;57:1221–1226
Op den Kamp JAF: Lipid asymmetry in membranes. Annu Rev Biochem 1979;48:47–71
Nakashima S, Suganuma A, Matsui A, Nozawa Y: Thormobin induces a biphasic 1,2-diacyl glycerol production in human platelets. Biochem J 275:355–361
Dale MP, Robinson NC: Synthesis of cardiolipin derivatives with protection of the free hydroxyl: Its application to the study of cardiolipin stimulation of cytochrome c oxidase. Biochemistry 1988;27:8270–8275
Rand JH, WU XX, Guller S, Gil J, Guha A, Scher J, Lockwood CJ: Reduction of annexin V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566–1572
Kirkun G, Lockwood CJ, Wu XX, Zhou XD, Guller S, Calandri C, Guha A, Nemerson Y, Rand JH: The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and in vitro regulation. Placenta 1994;15:601–612
Romisch J, Schorlemmer V, Fickenscher K, Paques EP, Heimburger N: Anticoagulant properties of placental protein 4 (annexin V). Thromb Res 1990;60:355–366
Rimarchin JA, Zaninovic N, Vuck LL, Posenwaks Z: Programmed cell death (apoptosis) in human gametes and preembryos in vitro. Hum Reprod 1997;12:39
Kaider BD, Purvis MT, Kovacs L, Coulam CB, Roussev RG: In vitro effect of antiphospholipid, antinuclear and antithyroid antibodies upon murine cultured embryos. Am J Reprod Immunol 1996;35:459
Coulam CB: Implantation failure and immunotherapy. Hum Reprod 1995;10:1338–1340
Tan EM, Cohen AS, Fries JE, et al.: The 1982 revised criteria for classification of systemic lupus erythematosis. Arth Rheum 1982;25:127–132
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coulam, C.B., Kaider, B.D., Kaider, A.S. et al. Antiphospholipid Antibodies Associated with Implantation Failure After IVF/ET. J Assist Reprod Genet 14, 603–608 (1997). https://doi.org/10.1023/A:1022588903620
Issue Date:
DOI: https://doi.org/10.1023/A:1022588903620